(1,10,11,12,14,23-Hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo(12.12.0.02,11.04,9.015,25.018,23.019,25)hexacosan-22-yl) 2-methylbut-2-enoate

HCID 5658CAS 8051-02-3

Basic information

Standard SMILES
CC=C(C)C(=O)OC1CCC2(C)C3CCC4C5(O)CC(O)C6(O)C(CN7CC(C)CCC7C6(C)O)C5(O)CC42OC13O
InChIKey
DBUCFOVFALNEOO-UHFFFAOYSA-N
Molecular formula
C32H49NO9
Average molar mass
591.7 g/mol
Monoisotopic mass
591.34073215

Overview

(1,10,11,12,14,23-Hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl) 2-methylbut-2-enoate has been reported in Veratrum viride with data available.

Names & identifiers

Preferred name
(1,10,11,12,14,23-Hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo(12.12.0.02,11.04,9.015,25.018,23.019,25)hexacosan-22-yl) 2-methylbut-2-enoate
IUPAC
(1,10,11,12,14,23-hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl) 2-methylbut-2-enoate

Names & synonyms

RefChem:1049189(1,10,11,12,14,23-Hexahydroxy-6,10,19-trimethyl-24-oxa-4-azaheptacyclo(12.12.0.02,11.04,9.015,25.018,23.019,25)hexacosan-22-yl) 2-methylbut-2-enoateSCHEMBL30467143DTXSID508616038051-02-3AAA06259NS000084684,12,14,16,17,20-Hexahydroxy-4,9-epoxycevan-3-yl 2-methylbut-2-enoate

Database identifiers

CAS
8051-02-3
PubChem CID
5658
DTXSID
DTXSID50861603
EC Number
617-100-0

Properties

Computed structural properties

XLogP
0.6
Topological polar surface area
160 Ų
Hydrogen bond donors
6
Hydrogen bond acceptors
10
Rotatable bonds
3
Heavy atoms
42

Safety & regulation

GHS classification

GHS Classification · 3 items

Warning

H315: Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Hazard information

Hazard Classes and CategoriesEye irritation - category 2

Related reactions

0 records

No reaction records under the current filter.

Linked notes

Loading…